We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Rx-360 Receives Mixed Reviews on Sharing Audits
Rx-360 Receives Mixed Reviews on Sharing Audits
September 8, 2009
The drug industry is expressing some skepticism about relying on an Rx-360 Consortium plan to conduct and share supply-chain audits, as the months-old consortium sets up working groups toward that end.